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Over the past four decades it has become clear that prostaglandin E2 (PGE2), a
phospholipid-derived signaling molecule, plays a fundamental role in modulating the
gonadotropin-releasing hormone (GnRH) neuroendocrine system and in shaping the hypo-
thalamus. In this review, after a brief historical overview, we highlight studies revealing that
PGE2 released by glial cells such as astrocytes and tanycytes is intimately involved in the
active control of GnRH neuronal activity and neurosecretion. Recent evidence suggests
that hypothalamic astrocytes surrounding GnRH neuronal cell bodies may respond to neu-
ronal activity with an activation of the erbB receptor tyrosine kinase signaling, triggering the
release of PGE2 as a chemical transmitter from the glia themselves, and, in turn, leading
to the feedback regulation of GnRH neuronal activity. At the GnRH neurohemal junction,
in the median eminence of the hypothalamus, PGE2 is released by tanycytes in response
to cell–cell signaling initiated by glial cells and vascular endothelial cells. Upon its release,
PGE2 causes the retraction of the tanycyte end-feet enwrapping the GnRH nerve termi-
nals, enabling them to approach the adjacent pericapillary space and thus likely facilitating
neurohormone diffusion from these nerve terminals into the pituitary portal blood. In view
of these new insights, we suggest that synaptically associated astrocytes and perijunc-
tional tanycytes are integral modulatory elements of GnRH neuronal function at the cell
soma/dendrite and nerve terminal levels, respectively.
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INTRODUCTION
Sexual development, puberty, and adult fertility are achieved by
events that are initiated within the central nervous system and
require the maturation and function of a neural network that
transmits both homeostatic and external cues to the discrete
hypothalamic neuronal population that releases gonadotropin-
releasing hormone (GnRH) from neuroendocrine terminals
within the median eminence into the pituitary portal vessels to
control gonadotropins (luteinizing hormone,LH and follicle stim-
ulating hormone, FSH) secretion (Terasawa and Fernandez, 2001;
Herbison andNeill,2006;Malpaux,2006;Ojeda andSkinner,2006;
Plant, 2006; Donato et al., 2011). In turn, these gonadotropins act
on the ovaries and testis to regulate the secretion of sex steroids
and the production of eggs and sperm.
In addition to neurons, accumulating evidence over the past
two decades indicates that glial cells, and in particular astrocytes
and tanycytes, also contribute to the neural network that con-
verges onto GnRH neurons to control reproduction. Both the
neuronal and glial elements of this GnRH neural network are
subject to the direct modulatory inﬂuence of gonadal steroids
(Garcia-Segura and McCarthy, 2004; Ronnekleiv and Kelly, 2005;
Mong and Blutstein, 2006; Wintermantel et al., 2006; Christ-
ian and Moenter, 2010; Prevot et al., 2010a; Bellefontaine et al.,
2011). Although neuronal elements regulate the activity of GnRH
neurons through a complex array of excitatory and inhibitory
synaptic inputs, glial cells communicate with GnRH neurons via
the activation of speciﬁc growth-factor-dependent signaling path-
ways (reviewed in Melcangi et al., 2002; Herbison and Neill, 2006;
Mahesh et al., 2006; Ojeda and Skinner, 2006; Sharif and Prevot,
2010).
The main glial population in the brain consists of astrocytes
that ensheathe synapses and are in contact with blood vessels.
They regulate blood ﬂow, provide much-needed energy to neu-
rons, and supply the building blocks for neurotransmitters at the
synapses, in addition to dynamically contributing to informa-
tion processing within the central nervous system (Haydon and
Carmignoto, 2006; Martineau et al., 2006; Iadecola and Neder-
gaard, 2007; Eroglu and Barres, 2010; Halassa and Haydon, 2010;
Pfrieger, 2010; Di Castro et al., 2011; Panatier et al., 2011), includ-
ing the hypothalamus (Hatton and Wang, 2008; Theodosis et al.,
2008; Gordon et al., 2009; Panatier, 2009; Oliet and Bonfardin,
2010). Tanycytes are elongated radial glial cells that have many fea-
tures in common with astrocytes and are closely associated with
neuroendocrine terminals in the median eminence of the hypo-
thalamus (Theodosis et al., 2008; Prevot et al., 2010a,b; Dale, 2011;
Sild and Ruthazer, 2011). As integrative hubs, astrocytes and tany-
cytes likely play a fundamental role in shaping and regulating the
GnRH system.
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Here, we will review recent ﬁndings that illustrate the remark-
able interplay between glia and neurons within the hypothalamo-
hypophyseal–gonadal axis, and show that different glial cell types
regulate different aspects of the architecture, function, and plas-
ticity of the GnRH system through dynamic and often multidi-
rectional interactions with specialized neuronal junctions, such as
synapses and neurohemal junctions. We will mainly restrict our
focus to the roles of hypothalamic astrocytes and tanycytes sub-
served by the release of prostaglandin E2 (PGE2), a molecule that
has long been known to regulate GnRH neuronal function and has
recently been identiﬁed as a gliotransmitter.
PROSTAGLANDIN E2 AND THE CENTRAL CONTROL OF REPRODUCTION
Prostaglandin E2 is one of a number of prostanoids synthesized
from arachidonic acid, which is produced from membrane phos-
pholipids by a phospholipase A2. Arachidonic acid is converted to
bioactive prostanoids by the cyclooxygenases (COX-1 and COX-
2) and a class of terminal synthases (see for review Bosetti, 2007;
Figure 1). Several studies suggest that PGE2 is mainly derived
from the COX-2 pathway (Brock et al., 1999; Vidensky et al., 2003;
Sang et al., 2005). PGE2 signaling is propagated by four G-protein-
coupled receptors, EP1–EP4 (see for review Coleman et al., 1994;
Figure 1).
Prostaglandin E2 has been known to play a role in the central
control of reproduction for more than 35 years. The ﬁrst indica-
tion that PGE2 was involved in the process of GnRH secretion
was provided by experiments showing that PGE2 injected into
the third ventricle of the rat brain induced the release of LH
into the general circulation (Harms et al., 1973) and of GnRH
into the pituitary portal blood vessels (Eskay et al., 1975; Ojeda
et al., 1975b). A similar stimulatory effect of PGE2 on GnRH
release has also been documented in monkeys using push–pull
perfusion in conscious animals (Gearing and Terasawa, 1991).
To bring about the activation of the GnRH axis, PGE2 acts at
two main hypothalamic sites: the preoptic-anterior hypothalamic
region in which GnRH cell bodies reside, and the tuberal region
of the hypothalamus, which contains the median eminence and
GnRH-releasing neuroendocrine terminals (Ojeda et al., 1977).
The use of COX inhibitors such as indomethacin has provided
further support for a physiological role of the prostaglandins in
the control of GnRH release. Indomethacin administration sup-
presses the LH surge induced by estradiol during anestrus in ewes
(Carlson et al., 1974) and during the early follicular phase in rhe-
sus monkeys (Carlson et al., 1977). In rats, the intraventricular or
intrahypothalamic administration of indomethacin inhibits both
pulsatile LH release and the LH discharge induced by ovarian
steroids (Ojeda et al., 1975a). Other studies have demonstrated
that the microinjection of either aspirin, a non-steroidal COX
inhibitor, or N-0164, a prostaglandin and thromboxane antago-
nist, into the tuberal region of the rat hypothalamus results in the
suppression of ovulation (Labhsetwar and Zolovick, 1973; Botting
et al., 1977). Finally, experiments conducted using hypothalamic
explants in vitro have revealed that PGE2 is an effective stimulator
of GnRHrelease frommedian eminence nerve terminals (Gallardo
and Ramirez, 1977; Ojeda et al., 1979, 1986b).
A sizable body of evidence also implicates PGE2 as a phys-
iological component of the GnRH system during postnatal
FIGURE 1 | Prostaglandin E2 (PGE2) biosynthesis and signaling. Upon
its release from plasma membrane phospholipids by phospholipase A2,
arachidonic acid is converted to the unstable endoperoxide intermediates,
prostaglandin G2 (PGG2), and prostaglandin H2 (PGH2) by the
cyclooxygenases (COX-1 and COX-2, encoded by separate genes). Both
COX isoforms catalyze the same reactions, but while COX-1 is
constitutively expressed, COX-2 is rapidly and transiently upregulated by
cytokines and growth factors. Terminal synthases convert both PGG2 and
PGH2 into prostaglandins [PGE2, PGD2, PGF2α, prostacyclin (PGI2)], and
thromboxane (TxA2). Once synthesized, PGE2 immediately diffuses away
and activates its speciﬁc E-prostanoid receptors (EP1–4), which belong to
the family of seven-transmembrane G-protein-coupled receptors. EP2 and
EP4 are coupled to Gs and stimulate the adenylyl cyclase (AC)–cyclic
adenosine monophosphate (cAMP)–protein kinase A (PKA) pathway. In
contrast, EP3 is coupled to Gi and inhibits AC activation, resulting in
decreased cAMP concentrations. EP1 is thought to be coupled to the
Gq-phospholipase C (PLC) pathway, leading to an elevation of free cytosolic
calcium concentrations (Milatovic et al., 2011). Notably, an examination of
the capacity of the hypothalamus to metabolize arachidonic acid through
the COX pathway has revealed a pubertal increase in the formation of
PGE2, particularly during the ﬁrst proestrus (Ojeda and Campbell, 1982).
Intriguingly, the increase in PGE2 synthesis is not associated with changes
in the formation of PGF2α, PGI2, PGD2, or thromboxane A2 from exogenous
arachidonic acid, suggesting that it is a speciﬁc event directly associated
with the peripubertal activation of the reproductive hypothalamus (Ojeda
and Campbell, 1982). Such a selective synthesis of PGE2 has also been
shown to be triggered by estrogens during early postnatal development
(Amateau and McCarthy, 2002).
development. For instance, PGE2 can induce the release of GnRH
long before puberty in both mice and rats (Ojeda et al., 1986a; Pre-
vot et al., 2003b). As puberty approaches, the increasing output of
estradiol from the developing ovaries induces a preovulatory surge
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of GnRH/LH.Biochemical analyses at this last phase of sexualmat-
uration have demonstrated that the capacity of the reproductive
hypothalamus to metabolize arachidonic acid through the COX
pathway leads to a speciﬁc increase in PGE2 synthesis (Figure 1),
particularly during the ﬁrst proestrus (Ojeda andCampbell, 1982).
This effect appears to be estrogen-dependent since it is mimicked
by the treatment of juvenile animals (early post-weaning period)
with estradiol at doses capable of inducing a preovulatory surge
of LH (Ojeda and Campbell, 1982). More recent studies have
shown that an estradiol-induced increase in hypothalamic PGE2
levels can be seen even in newborn rats (Amateau and McCarthy,
2002). Intriguingly, experiments showing that estradiol treatment
upregulates bothCOX-2mRNAandprotein synthesis in the hypo-
thalamus of female rats during postnatal development (Amateau
and McCarthy, 2004) raise the possibility that estrogens may act
on COX-2 expression to promote PGE2 synthesis at puberty.
Since the levels of arachidonic acid in tissue phospholipids
are to some degree inﬂuenced by the dietary intake of different
polyunsaturated fatty acids (e.g., linoleic acid), malnutrition dur-
ing early life could cause deﬁcits in arachidonic acid synthesis (de
Souza et al., 2011; Lauritzen and Carlson, 2011), which in turn
could lead to changes in the production of prostaglandins and
thus interfere with the maturation of the GnRH system. Indeed, a
diet-related deﬁciency of essential fatty acids initiated before fer-
tilization in female rats has been shown to signiﬁcantly delay the
onset of reproductive capacity in female offspring without affect-
ing the progression of gestation or the delivery of healthy litters by
the dams (Smith et al., 1989). In this study, delayed puberty was
associated with reduced PGE2 synthesis within the hypothalamus.
The deﬁcit did not appear to be due to the impairment of COX
activity, but to diminished arachidonic acid bioavailability (Smith
et al., 1989).
GLIA, THE MAIN SOURCE OF PROSTAGLANDIN E2 WITHIN THE GnRH
NEUROSECRETORY SYSTEM
Although PGE2 was initially postulated to be an intracellular mes-
senger produced by the binding of neurotransmitters to receptors
located on GnRH neurons and acting within these neurons (Ojeda
et al., 1982; Gearing and Terasawa, 1991; Rettori et al., 1992),
this concept has been revisited following studies showing that
the actions of PGE2 on GnRH release are initiated by its binding
to speciﬁc membrane receptors (Coleman et al., 1994) expressed
by GnRH neurons (Rage et al., 1997) and the recognition that
astrocytes represent a major source of PGE2 in the brain (Ma
et al., 1997; Bezzi et al., 1998; Hirst et al., 1999). Two decades ago,
seminal studies by Ojeda and colleagues revealed that the PGE2-
mediated activation of GnRHneuronal secretory activity triggered
by estrogen at the time of puberty required the activation of
growth-factor-dependent glial signaling pathways involving recep-
tor tyrosine kinases of the erbB family (Ojeda et al., 1990; Junier
et al., 1991; Ma et al., 1992).
Of the four known members of the erbB family (Figure 2),
three of them, erbB1, erbB3, and erbB4, bind and are activated
by cognate ligands. In contrast, erbB2 has no known ligand, and
functions primarily as a modulator of the other members of the
family (Hynes andLane,2005).While erbB receptors donot appear
to be expressed in GnRH neurons (Ma et al., 1994b, 1999; Voigt
FIGURE 2 |The erbB family of receptors and their ligands. ErbB1 (or
EGFR, epidermal growth factor receptor) and erbB4 are fully functional
receptors that possess an extracellular ligand-binding domain and a
cytoplasmic protein tyrosine kinase domain and can function as homo- or
heterodimers. In contrast, erbB2 (or neu), which lacks a ligand-binding
domain, and erbB3, which is defective in its intrinsic tyrosine kinase activity
(dashed lines), must heterodimerize with another member of the erbB
family for signal transduction. The different EGF-like growth factors exhibit
different binding speciﬁcities for the erbB receptors.While TGFα, EGF,
amphiregulin, epigen, neuregulin-3, and neuregulin-4 are speciﬁc for a
single member of the receptor family, the ﬁve other EGF-like ligands can
bind two or three receptors each. EGF, epidermal growth factor; HB-EGF,
heparin binding-EGF; TGFα, transforming growth factor α.
et al., 1996; Prevot et al., 2003b), erbB1, erbB2, and erbB4, but
not erbB3, are expressed in hypothalamic astrocytes, known to
morphologically and physically interact with GnRH cell bodies
(Witkin et al., 1995;Cashion et al., 2003;Baroncini et al., 2007; San-
dau et al., 2011a) both in rodents and humans (Figures 3 and 4;Ma
et al., 1999; Prevot et al., 2003b; Sharif et al., 2009). In addition,
hypothalamic astrocytes express the erbB1 ligand, transforming
growth factor alpha (TGFα; Figure 4), and several forms of the
erbB4 ligand, neuregulin (Ma et al., 1992, 1994a, 1999; Sharif et al.,
2009). Importantly, gonadal steroids have been found to induce
dramatic increases in the expression levels of the erbB receptors
and their ligands within the hypothalamus at puberty; no such
changes are seen in the cortex or other brain regions unrelated to
reproductive control (Ma et al., 1992, 1994a, 1999).
The pharmacological or genetic inhibition of erbB1, erbB2,
and/or erbB4 receptors delays the onset of puberty (Ma et al.,
1992; Apostolakis et al., 2000; Prevot et al., 2003b, 2005) and alters
adult reproductive function in rodents (Prevot et al., 2005). In vitro
studies using either hypothalamic explants or primary cultures of
hypothalamic astrocytes with a GnRH-producing neuronal cell
line have shown that erbB receptor ligands can stimulate GnRH
release from the explants or neuronal cells, but do so indirectly, by
inducing astrocytes to secrete PGE2 (Ojeda et al., 1990; Ma et al.,
1997, 1999; Prevot et al., 2003b, 2005). In addition, ligand activa-
tion of erbB receptors has been shown to promote morphological
rearrangements in hypothalamic astrocytes (Figure 4G–I; Sharif
et al., 2009) thus raising the possibility that erbB signaling may
also inﬂuence the astrocytic coverage of GnRH neurons in vivo
(see for review Prevot et al., 2010b).
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FIGURE 3 | Astrocytes morphologically interact with GnRH neurons
and express erbB4 receptors in the tuberal region of the human
hypothalamus. (A–C) Photomicrographs showing a GnRH neuronal cell
body (green) to which the processes of glial ﬁbrillary acidic protein
(GFAP)-immunoreactive astrocytes (red, arrows) are abundantly apposed.
Cell nuclei are stained with Hoechst (blue). Adapted from (Baroncini et al.,
2007) with permission. (D–F) GFAP-immunoreactive astrocytes (red) of the
tuberal region of the human hypothalamus express erbB4 receptors (green;
M. Baroncini and V. Prevot, unpublished data). Scale bars=20μm (C),
10μm (F).
In vitro experiments suggest that erbB signaling in hypothal-
amic astrocytes is functionally connected to the neuronal gluta-
matergic system, the primary mode of excitatory transsynaptic
communication used by hypothalamic neurons (van den Pol and
Trombley, 1993), and one that is known to increase GnRH secre-
tion (Donoso et al., 1990; Claypool et al., 2000) and accelerate
the initiation of puberty in both rodents and primates (Urban-
ski and Ojeda, 1987, 1990; Plant et al., 1989). In hypothalamic
and non-hypothalamic astrocytes alike (Bezzi et al., 1998; Zonta
et al., 2003a,b), transmitter spillover from nearby synaptic activ-
ity results in an elevation of PGE2 release (McCarthy et al., 2008;
Glanowska and Moenter, 2011). For example, neuronally released
glutamate can engage biochemical signaling in astrocytes through
the co-activation of AMPA and metabotropic glutamate receptors
to cause a ligand-dependent increase in astrocytic erbB signaling
and PGE2 release (Dziedzic et al., 2003). This in turn signals back
to GnRH neurons (Figure 5) facilitating neuroendocrine devel-
opment and adult reproductive function (Prevot et al., 2003b,
2005).
PROSTAGLANDIN E2, A NEWLY UNCOVERED GLIOTRANSMITTER
WITHIN THE GnRH NEUROSECRETORY SYSTEM
Even though PGE2 has been known to trigger GnRH release from
the hypothalamic neurons controlling reproduction for almost
40 years, it is only very recently that it has been identiﬁed as a
potent excitatory regulator of GnRH neuronal activity, both in
male and female mice (Clasadonte et al., 2011). Using patch-
clamp recordings in brain slices from transgenic mice expressing
green ﬂuorescent protein (GFP) under the control of the GnRH
promoter, we showed that PGE2 induced a reversible membrane
depolarization of GnRH neurons leading to the initiation of
spike ﬁring via the postsynaptic effect involving activation of a
non-selective cation current (Figure 5; Clasadonte et al., 2011)
reminiscent of the ones recently described in GnRH neurons by
other groups (Zhang et al., 2008; Roland and Moenter, 2011).
Although GnRH neurons are known to express both the EP1
and EP2 subtypes of prostaglandin receptors in vivo (Rage et al.,
1997; Jasoni et al., 2005), the excitatory effect of PGE2 on GnRH
neuronal activity was selectively mimicked by the EP2 receptor
agonist butaprost (Clasadonte et al., 2011) previously shown to
promote GnRH release in the GnRH-producing neuronal cell
line, GT1–7 (Rage et al., 1997). The PGE2-mediated membrane
depolarization of GnRH neurons was also shown to require the
cAMP/protein kinase A (PKA) pathway (Clasadonte et al., 2011),
which is known to be coupled to the EP2 receptor (Figure 1;
Coleman et al., 1994; Sang et al., 2005) and to underlie the stim-
ulatory effect of PGE2 on GnRH secretion (Figure 5; Ojeda et al.,
1985).
As alluded to above, the selective disruption of erbB4 signal-
ing in astrocytes by the overexpression of a dominant-negative
erbB4 receptor under the control of the human GFAP promoter
leads to diminished PGE2 release in response to ligand-dependent
erbB4 activation, leading in turn to reducedGnRH release, delayed
puberty, and disrupted adult reproductive function (Prevot et al.,
2003b, 2005). Intriguingly, electrophysiological analyses have
shown that the spontaneous activity of GnRH neurons in these
animals is decreased and that this deﬁciency is mimicked by the
bath application of either ﬂuoroacetate, an inhibitor of astrocyte
metabolism (Fonnum et al., 1997;Henneberger et al., 2010), or the
COX blocker indomethacin, to slices of the preoptic region from
wild-type animals (Clasadonte et al., 2011). The fact that GnRH
neuronal activity in all these conditions can be rescued by exoge-
nous PGE2 (Clasadonte et al., 2011) strongly suggests that glial
PGE2 is an important component of the homeostatic mechanism
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FIGURE 4 | Human hypothalamic astrocytes express the molecular
components required for a glia-to-neuron communication through the
erbB-prostaglandin signaling system. Primary cultures of human
hypothalamic astrocytes have been prepared from 9 to 12-week-old human
fetuses (A). The cultures are composed of 98% of cells immunopositive for
the astrocytic markers GFAP [(B) green] and the glutamate–aspartate
transporter GLAST [(C) red]. Note that cells that express GFAP at low to
undetectable levels are nevertheless strongly immunopositive for GLAST
(arrows). (D) Human astrocytes in culture expressTGFα protein (red). (E)
Western blot analysis of erbB receptor expression in primary cultures of
human cortical and hypothalamic astrocytes.While all four erbB receptors
are expressed in the fetal brain, hypothalamic astrocytes (Hyp astro) express
erbB1, erbB2, and erbB4, but not erbB3, and cortical astrocytes (Ctx astro)
express erbB1, erbB2, and erbB3 but not erbB4 receptors. IB, immunoblot.
(F) Human hypothalamic astrocytes in culture are immunopositive for COX
(green). (G–I) EGF ligands induce profound morphological rearrangements
of human hypothalamic astrocytes in vitro. Cell morphology was examined
by visualization of the actin cytoskeleton using Alexa Fluor 568-conjugated
phalloidin (red). Hypothalamic astrocytes exhibit heterogeneous shapes
under control conditions, i.e., polygonal cells, cells with short and thick
extensions (asterisk) or long and thin processes (arrow) (G). TGFα (50 ng/mL
for 3 days) stimulates the extension of long and thin processes (arrows) and
the apparition of bipolar cells (double arrows) (H) while treatment with
neuregulin-1 NRGβ1 (50 ng/mL for 3 days) increases the number of
multipolar cells with thick processes (arrowheads) (I). Nuclei are
counter-stained with Hoechst [(B,C,F–I), blue]. Scale bars=3mm (A),
50μm (B,C,F), 20μm (D), 100μm (G–I). Adapted from (Sharif et al., 2009)
with permission.
controllingGnRHneuronal excitability. The role of glia in the con-
trol of GnRH neuronal activity is further supported by a recent
study demonstrating that glial prostaglandins may regulate the
efﬁcacy of GABAergic inputs to GnRH neurons in ovariectomized
mice (Glanowska and Moenter, 2011). Using GnRH–GFP trans-
genic mice and patch-clamp recordings in brain slices, the authors
demonstrated that the repeated action-potential-like depolariza-
tion of a GnRH neuron caused a short-term reduction in the
frequency of spontaneous GABAergic postsynaptic currents in
the same neuron, suggesting the presence of local circuit inter-
actions between GnRH neurons and their GABAergic afferents
(Chu and Moenter, 2005; Glanowska and Moenter, 2011). It is
important to note that in this local circuit, the activation of GABAA
receptors exerts a depolarizing action that can trigger actionpoten-
tial ﬁring due to the elevated chloride levels maintained in adult
GnRH neurons (DeFazio et al., 2002; Han et al., 2002; Herbi-
son and Moenter, 2011). Consequently, this represents a negative
feedback loop in which depolarized GnRH neurons reduce the
activity of their own excitatory GABAergic afferents. In addition
to being steroid-dependent and under the inﬂuence of both glu-
tamatergic and endocannabinoid signaling mechanisms via the
activation of presynaptic metabotropic glutamate receptors and
cannabinoid CB1 receptors respectively (Chu and Moenter, 2005;
Glanowska and Moenter, 2011) this local negative feedback loop
also requires the actionof glial-derivedprostaglandins (Glanowska
and Moenter, 2011). Indeed, the incubation of brain slices with
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FIGURE 5 | Prostaglandin E2 acts as a gliotransmitter to stimulate
GnRH neuron electrical activity. Neuronally released glutamate (Glu) (1)
co-activates metabotropic glutamatergic (mGluR) and AMPA glutamatergic
receptors (GluR) in astrocytes (2), stimulating the activity of
zinc-dependent matrix metalloproteinases (MMPs) of the ADAM (a
disintegrin and metalloproteinase) family (3). The MMPs catalyze
ectodomain shedding of the pro-EGF ligands pro-TGFα and pro-NRG
(pro-neuregulin). In particular, the processing of pro-TGFα has been shown
to involve the metalloproteinase ADAM17, also known as tumor necrosis
factor α converting enzyme (TACE). The subsequently released mature
TGFα and NRG activate erbB1/erbB2 and erbB4/erbB2 heterodimers,
respectively (Dziedzic et al., 2003). The co-activation of glutamatergic
receptors induces the recruitment of erbB1, erbB4, and their pro-ligands to
the cell membrane, where multiprotein complexes form, as demonstrated
by the direct physical association of glutamatergic and erbB receptors (not
shown). The activation of erbB receptors in hypothalamic astrocytes
promotes profound morphological changes, including the retraction of
cytoplasm, stellation of cells and the elongation of processes (see
Figure 4G–I) (4′). The activation of erbB receptors also promotes the
release of PGE2 (Ma et al., 1997, 1999; Dziedzic et al., 2003) (4), which
stimulates a cAMP/protein kinase A (PKA) pathway in GnRH neurons
through the mobilization of EP2 receptors (EP2; Clasadonte et al., 2011)
(5). Activation of this signaling pathway induces a reversible membrane
depolarization of GnRH neurons leading to the initiation of spike ﬁring via a
postsynaptic effect involving the activation of a non-selective cation
current (Clasadonte et al., 2011) (6).
indomethacin, the broad-spectrum prostaglandin receptor antag-
onist AH 6809, or ﬂuorocitrate, which like ﬂuoroacetate, is a spe-
ciﬁc blocker of astrocyte metabolism, prevents the depolarization-
induced suppression of GABAergic transmission in GnRH neu-
rons (Glanowska and Moenter, 2011). Since GABA exerts a depo-
larizing action in this local circuit, we could envisage that glial
prostaglandins, by suppressing excitatory drive, would reduce
GnRH neuronal activity. Estradiol could also differentially inﬂu-
ence this local inhibitory feedback to exert its positive or negative
feedback effects (Glanowska and Moenter, 2011). Thus, in addi-
tion to exerting a direct postsynaptic excitatory action on the cell
body of GnRH neurons, prostaglandins released from astrocytes
can also participate in mechanisms that regulate the activity of
their GABAergic presynaptic inputs (Figure 5). In the GnRH sys-
tem, thus, PGE2 fulﬁlls all the criteria that qualify a compound as
a “gliotransmitter” (Parpura and Zorec, 2010): (i) it is synthesized
by astrocytes, (ii) its regulated release is triggered by physiolog-
ical stimuli, (iii) it acutely activates the ﬁring of GnRH neurons
and modulates the activity of their GABAergic afferents, and (iv)
it plays a role in an important physiological function, i.e., the
neuroendocrine control of reproduction, which is vital to species’
survival.
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A ROLE FOR ASTROGLIAL PROSTAGLANDIN E2 IN DENDRITIC SPINE
PLASTICITY IN GnRH NEURONS?
Gonadotropin-releasing hormone neurons exhibit a simple bipo-
lar morphology (Figure 3A) with one or two very long dendritic
processes that can extend up to 1mm (Campbell et al., 2005,
2009). Intriguingly, recent studies have demonstrated that the den-
sity of spines along these dendrites is subject to robust increases
not only during sexual development in immature animals (Cot-
trell et al., 2006), but also at the onset of the GnRH/LH surge
induced by gonadal steroids in ovariectomized adult mice (Chan
et al., 2011). Although sexual maturation and the surge mech-
anism have been shown to require the neuronal expression of
sex-steroid receptors (Wintermantel et al., 2006;Raskin et al., 2009;
Mayer et al., 2010), studies suggesting that astrocytic mechanisms
might control the stabilization of individual dendritic processes
and their subsequent maturation into spines (Nishida and Okabe,
2007), together with the demonstration that speciﬁc juxtacrine
signaling pathways are involved in sculpting astrocyte–dendritic
spine interactions (Murai et al., 2003), raise the possibility that
astrocytes play a role in the physiological changes of synaptic
structure underlying GnRH neuronal maturation and function.
PGE2 release by astrocytes could be central in this process and
PGE2 has in fact been shown to mediate the dramatic neu-
ronal spine plasticity induced by estrogens in the developing
preoptic region (Amateau and McCarthy, 2002, 2004; Wright and
McCarthy, 2009). This effect involves the activation of AMPA and
metabotropic glutamate receptors (Amateau and McCarthy, 2002;
Wright and McCarthy, 2009), known to promote erbB-dependent
PGE2 release in hypothalamic astrocytes (Dziedzic et al., 2003), as
well as the EP2/PKA signaling pathway (Amateau and McCarthy,
2002), recently found to be functional in native GnRH neurons
(Clasadonte et al., 2011; Figure 5). Importantly, estrogens, which
have long been known to regulate neuronal spine plasticity in
the adult hippocampus (Woolley and McEwen, 1992, 1994), have
also been shown to promote comparable changes in the imma-
ture hippocampus (Amateau and McCarthy, 2002). However, in
the hippocampus, the underlying mechanisms do not appear to
require PGE2 synthesis (Amateau andMcCarthy,2002), suggesting
that increases in PGE2 synthesis are selectively used by estrogens
to promote dendritic spine plasticity in the developing preoptic
region. Further studies are required to determine whether estro-
genic effects on the plasticity of hypothalamic neurons such as
those seen in newborn rodents can also occur later in postnatal
life and/or in adulthood.
PROSTAGLANDIN E2 IS A KEY MEDIATOR OF GnRH RELEASE,
NEURONAL–GLIAL–ENDOTHELIAL INTERACTIONS, AND CELL
PLASTICITY AT THE GnRH NEUROHEMAL JUNCTION
Neuroendocrine GnRH neurons send axons to the median emi-
nence, where they release their neurohormone into the pituitary
portal blood vessels for delivery to the anterior pituitary. The
median eminence, which lies ventral to the third ventricle in the
tuberal region of the hypothalamus, constitutes one of the key sites
for the regulation of GnRH release (see for review Hrabovszky
and Liposits, 2008; Ojeda et al., 2008; Prevot et al., 2010a; Yin
and Gore, 2010). The modulation of GnRH release by PGE2
within the median eminence was suggested as soon as in vitro
systems to statically incubate median eminence nerve terminals
were developed, i.e., in the late 70s (Negro-Vilar et al., 1979; Ojeda
et al., 1979). Experiments showing that the PGE2-induced GnRH
release from median eminence explants requires the mobiliza-
tion of intracellular calcium stores (Ojeda and Negro-Vilar, 1985;
Ojeda et al., 1988) have suggested a role for the EP1 receptor in
this process (Figure 1). In line with this assumption are other
ﬁndings demonstrating that GnRH neurons express EP1 receptors
in vivo and that the EP1 agonist 17-phenyl trinor PGE2 promotes
FIGURE 6 | Prostaglandin E2 promotes the retraction of tanycytic
processes in vitro and induces neuroglial plasticity causing GnRH
neurosecretory terminals to advance toward the pericapillary space in
isolated median eminence explants. (A)Tanycytes in culture were stained
with Alexa Fluor 568-conjugated phalloidin to visualize ﬁlamentous actin (red)
and with Hoechst to stain nuclei (blue). In control unstimulated tanycyte
cultures, actin was localized adjacent to the cell membrane (top panel, cortical
actin, arrowheads) and was also diffused throughout the cytoplasm. PGE2
treatment (280 nM, 30min) promoted tanycyte retraction (bottom panel, long
arrowhead). (B) Electron micrographs of GnRH immunoreactive axon
terminals (big arrowhead, green) from female rat median eminence explants
incubated for 30min in the presence or absence of PGE2 (1μM). Under basal
unstimulated conditions (Control), GnRH nerve endings (big arrowhead,
green) were maintained at a distance from the brain basal lamina (white
arrow) delineating the pericapillary space (p.s., pink) by thick enclosing
tanycyte end-feet (Tan., yellow). PGE2 treatment caused the advancement of
GnRH axon terminals (big arrowhead, green) toward the brain basal lamina
(white arrow) and the apparent retraction of most of the astroglial sheath
(black arrows, yellow) from those neurosecretory terminals that were
separated from the fenestrated (small arrowhead) portal capillaries (Cap., red)
by only a few nanometers. end., endothelium. Scale bars=10μm (A), 1μm
(B). Reproduced from (de Seranno et al., 2010) with permission.
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GnRH release from GT1–1 cells in vitro (Rage et al., 1997) without
affecting GnRH neuronal ﬁring in brain slices (Clasadonte et al.,
2011).
Within the median eminence, GnRH axon terminals are inti-
mately associated with cell processes belonging to specialized
unciliated ependymal cells named tanycytes. Tanycyte cell bod-
ies are attached together at the apex by tight junctions (Mullier
et al., 2010) and line the ﬂoor of the third ventricle. They send
out long slender processes that eventually contact the pial sur-
face of the brain where the fenestrated pituitary portal vessels
reside, via end-feet (Page, 1994; Cioﬁ et al., 2009; Mullier et al.,
2010). These tanycyte end-feet not only enclose the GnRH nerve
terminals, possibly providing a diffusion barrier (Kozlowski and
Coates, 1985; Meister et al., 1988; Ugrumov et al., 1989; King and
Letourneau, 1994), but also display a high degree of structural
plasticity across the ovarian cycle in rats (Prevot et al., 1998, 1999).
During the estrous cycle, under basal conditions, e.g., in diestrus,
GnRH nerve terminals are completely wrapped up in tanycyte
end-feet (Prevot et al., 1998, 1999). In proestrus, following the
activation of the reproductive axis, the end-feet are retracted, pre-
sumably due to increasing levels of gonadal steroids (King and
Letourneau, 1994), thus allowing GnRH neurons to directly con-
tact the pericapillary space (Prevot et al., 1998). By analogy with
the function-related plasticity documented in the neural lobe of
the pituitary (Hatton, 1997), these data argue for the importance
of tanycyte structural rearrangement in delivering peak levels of
GnRH to the pituitary during the preovulatory surge. The intrigu-
ing possibility that PGE2 could be involved in the control of these
FIGURE 7 | Schematic representation of neural–glial–endothelial
interactions involved in the control of GnRH neurosecretion in the
median eminence. (A) Glial–neuronal interactions in the median eminence
involve the production of epidermal growth factor (EGF)-related peptides by
glial cells. Activation of erbB1/erbB2 and erbB4/erbB2 heterodimers byTGFα
and NRG, respectively, promotes the release of PGE2 from astrocytes. The
binding of TGFα to tanycytic erbB1 receptors results in the recruitment of
erbB2 co-receptors and signal transduction. The ligand-dependent activation
of erbB1 receptors in tanycytes results in biphasic plastic changes
characterized by an initial phase of tanycyte outgrowth (1) and a secondary
phase of retraction (5). Although the initial outgrowth (1) is independent of the
TGFβ1 system, the subsequent retraction requires PGE2 synthesis (2), a
PGE2-dependent increase in the production of TGFβ1 (3′) and matrix
metalloproteinase (MMP) activity (4). In addition to promotingTGFβ1
synthesis by tanycytes (3′), PGE2 released by tanycytes (2) and astrocytes is
able to directly stimulate GnRH release at nerve endings through the EP1
receptor (EP1)-mediated mobilization of intracellular calcium stores (3). (B)
Endothelial–neuronal interactions at the level of the median eminence involve
the production of nitric oxide (NO) by the endothelial cells of fenestrated
capillaries of the portal blood vessels. Upon its secretion, NO diffuses from its
source and stimulates the production of PGE2 from tanycytes. PGE2
promotes the release of GnRH into the blood stream by the direct stimulation
of nerve endings (3) and by promoting their access to the pericapillary space
by inducing cytoarchitectural changes in tanycyte end-feet (1–3′). Estrogens
are likely to be the key humoral factors involved in the orchestration of the
endothelia-to-glia communication that allows GnRH neurons to directly
contact the pituitary portal blood vessels on the day of proestrus. Estrogen
treatment upregulates COX expression in tanycytes and stimulates
endothelial nitric oxide synthase (eNOS) expression in median eminence
endothelial cells. Adapted from (Prevot, 2002) with permission.
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plastic phenomena arises from recent studies using either median
eminence explants (de Seranno et al., 2010) or primary cultures of
tanycytes isolated from the median eminence (Prevot et al., 2003a;
De Seranno et al., 2004; de Seranno et al., 2010; Figure 6). When
PGE2 is applied to median eminence explants at concentrations
known to stimulate GnRH release, structural remodeling occurs
at the neurohemal junction in a matter of minutes causing GnRH
neurosecretory terminals to advance toward thepericapillary space
(de Seranno et al., 2010), a phenomenon that probably results from
the retraction of tanycyte end-feet (Figure 6B), as suggested by
the PGE2-promoted tanycyte retraction seen in vitro (Figure 6A).
As extensively reviewed elsewhere (Prevot et al., 2010a,b; Belle-
fontaine et al., 2011), PGE2 synthesis in tanycytes of the median
eminence could be prompted by two independent but complimen-
tary cell-based mechanisms, one involving glial–glial interactions
set in motion by the paracrine activation of TGFα/erbB1 signal-
ing pathway in tanycytes, as depicted in Figure 7A (Prevot et al.,
2003a), and another involving endothelial–tanycyte interactions
and the release of nitric oxide (NO) by vascular endothelial cells,
which in turn directly modulates COX activity in tanycytes, as
described in Figure 7B (De Seranno et al., 2004; de Seranno et al.,
2010). Both pathways could be subject to the modulatory inﬂu-
ence of gonadal steroids, as estrogens are known to upregulate
both TGFα expression in astroglial cells (Ma et al., 1992, 1994a)
and COX expression in tanycytes (de Seranno et al., 2010). Finally,
the physiological importance of PGE2 in the cell–cell communi-
cation processes regulating GnRH release has been highlighted by
experiments in which the COX inhibitor indomethacin is infused
directly into themedian eminence, resulting in themarked impair-
ment of the rat ovarian cycle, which requires the coordinated
delivery of GnRH into the hypothalamo-hypophyseal portal sys-
tem (de Seranno et al., 2010). Indeed, the local inhibition of
prostaglandin synthesis has been shown to arrest the ovarian cycle
in either diestrus or estrus when GnRH release is low (Levine and
Ramirez, 1982) and GnRH neuroendocrine terminals are enclosed
by tanycyte end-feet (Prevot et al., 1998, 1999).
CONCLUSION
Several observations made over the last two decades have demon-
strated that PGE2 known for almost 40 years to play an important
role in the regulation of the hypothalamic–pituitary–gonadal axis,
is a transmitter released by astrocytes and tanycytes, and intimately
linked with GnRH neuronal function in both the preoptic region
and the median eminence of the hypothalamus, where the cell
bodies and the neuroendocrine terminals of GnRH neurons in
rodents are respectively located. However, many mysteries regard-
ing the underlying mechanisms remain unsolved. For example,
even though recent studies suggest thatGnRHneurons candirectly
communicate with neighboring astrocytes via juxtacrine signal-
ing pathways (Sandau et al., 2011a,b), a true understanding of
how these GnRH neurons interact with hypothalamic astrocytes
to modulate PGE2 gliotransmission is missing. Are these com-
munication processes involved in sculpting astrocyte–dendritic
spine interactions and in promoting the physiological changes in
synaptic structure that underlie GnRH neuronal maturation and
function? How is PGE2 released from hypothalamic astrocytes?
Now that a general strategy for the application of molecular
genetics to the study of neuron–glia interactions and gliotrans-
mission has been elucidated, the next several years should provide
an opportunity to begin to address these questions.
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